Pharma Major Lupin Limited (Lupin) announced that
its Japanese subsidiary, Kyowa Pharmaceutical Industry Co., Ltd. (Kyowa), has
entered into an agreement with I’rom Holdings Co,, Ltd., an integrated Japanese
healthcare provider, to acquire up to 100% of the outstanding shares of its
subsidiary I'rom Pharmaceutical Co., Ltd.
Established in 1947, IP is a specialty Injectables Company headquartered in Tokyo. For the fiscal year ended March 2011, IP recorded sales revenues of JPY 5,361 Million. IP has a significant presence in the DPC hospitals within Japan. Injectable products enjoy a significant usage in the DPC Hospital segment, and generic injectable penetration is slated to grow significantly in future. There are currently over 1,400 DPC hospitals in Japan, covering over 35% of all hospital beds nationwide, and a market size of USD 11 Billion.
In a separate development, Kyowa has entered into a strategic alliance involving comprehensive operational support to be provided by IH's site management organization (SMO) subsidiary Irom Co., Ltd for clinical studies conducted by Kyowa for the Japanese market. I’rom is known as the pioneer of the SMO business in Japan, and the alliance seeks to utilize I’rom's expertise to support Kyowa.
Established in 1947, IP is a specialty Injectables Company headquartered in Tokyo. For the fiscal year ended March 2011, IP recorded sales revenues of JPY 5,361 Million. IP has a significant presence in the DPC hospitals within Japan. Injectable products enjoy a significant usage in the DPC Hospital segment, and generic injectable penetration is slated to grow significantly in future. There are currently over 1,400 DPC hospitals in Japan, covering over 35% of all hospital beds nationwide, and a market size of USD 11 Billion.
In a separate development, Kyowa has entered into a strategic alliance involving comprehensive operational support to be provided by IH's site management organization (SMO) subsidiary Irom Co., Ltd for clinical studies conducted by Kyowa for the Japanese market. I’rom is known as the pioneer of the SMO business in Japan, and the alliance seeks to utilize I’rom's expertise to support Kyowa.
No comments:
Post a Comment